IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cancer, neoplasm	Recruiting	Early phase 1	2026-06-18		NCT07574346

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University People's Hospital	269

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University People's Hospital	Beijing	China	58

Clinical trials